EDBI (Singapore)
The rounds this investor is named on, who it invests beside, and where it shows up.
The rounds this investor is named on, who it invests beside, and where it shows up.
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Amity A global enterprise AI technology group | Series D+ ext. Developing, 4 sources | more than $100M financing total | 2026-11-02 | [ LEAD ] |
Universal Quantum A British startup seeking to build a working quantum computer | Series A |
| $100M |
| ~ 2026-10-05 |
| [ PART ] |
Deepgram Enterprise Voice AI: STT, TTS & Agent APIs | Series C ext. Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | n/a | 2026-08-18 | [ PART ] |
Lumilens Lumilens provides next-gen photonic interconnects for scaling AI compute infrastructure. | Series C Verified against 1 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $700M | 2026-08-06 | [ PART ] |
Horizon3.ai Provides a platform for authorized attacks on networks to identify weaknesses | Series E Verified against 1 of 10 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $250M | 2026-08-03 | [ PART ] |
Cellares Cellares specializes in advanced manufacturing technologies for cell therapy, targeting biopharmaceutical companies and healthcare providers. | Series D Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $50M | 2026-06-15 | [ PART ] |
Amity Solutions AI-powered software solutions for enterprise businesses to improve operations and decision-making. | Series D Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2026-03-25 | [ LEAD ] |
CesiumAstro CesiumAstro delivers scalable satellites, terminals, and software-defined systems for the missions that matter—built for performance, ready to deploy. | Series C Verified against 1 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $470M | 2026-02-02 | [ PART ] |
Cellares Cellares specializes in advanced manufacturing technologies for cell therapy, targeting biopharmaceutical companies and healthcare providers. | Series D Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $257M | 2026-01-28 | [ PART ] |
d-Matrix d-Matrix is redefining AI inference with memory-centric compute built for ultra-low latency, greater efficiency, and scalable AI infrastructure. | Series C Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $275M | 2025-11-12 | [ PART ] |
Multiplier Acquires specialist firms and builds AI tools inside them, retaining local brands and leadership. | Seed Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $27.5M | 2025-06-18 | [ PART ] |
Addepar Addepar is a global data and AI company serving the financial services ecosystem. | Series G Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $230M | 2025-05-13 | [ PART ] |
Callio Therapeutics Dual-payload antibody-drug conjugates (ADCs) for cancer treatment. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $187M | 2025-03-03 | [ PART ] |
Leo Cancer Care Leo Cancer Care makes upright radiation therapy systems that treat cancer patients seated or standing. | Series C Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | n/a | 2024-06-11 | [ PART ] |
Aspen Neuroscience Aspen Neuroscience develops personalized regenerative therapies, specifically autologous iPSC-derived cell replacement therapies for Parkinson's disease. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $147.5M | 2022-05-09 | [ PART ] |
Bolttech Embedded insurance platform | Series A Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | US$210M financing total | 2021-09-21 | [ PART ] |
Inari Innovative agricultural solutions leveraging AI and gene editing technology for plant breeding. | Series C Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $89M | 2019-08-06 | [ PART ] |